1. Chordia Therapeutics Inc.
  2. Investor Relations
  3. IR News
IR News
サブ-ナビゲーション
  • Company
  • Science/Pipleline
  • News
  • Investor Relations
    • Management Policies
    • Financial Information
    • IR Library
    • Stock Information
    • IR Calender
    • 現在位置:IR News
    • IR FAQ
    • Disclaimer
  • Career
  • Contact
  • Privacy Policy
  • Term of use
  • Sitemap

IR News

  • May 15, 2025 Notice Concerning Change of Major Shareholder pdf (249KB)
  • Apr 28, 2025 Notice of Discontinuation of Development of CTX-177 (ONO-7018) pdf (289KB)
  • Apr 25, 2025 Chordia presents new data at the American Association for Cancer Research Annual Meeting 2025 pdf (229KB)
  • Apr 24, 2025 Notice of Release of Transcript of Interim Financial Results Briefing for the Fiscal Year Ending August 31, 2025 pdf (276KB)
  • Apr 11, 2025 For 2nd quarter FY8 2025 Financial Results Presentation pdf (1,132KB)
  • Apr 11, 2025 Non-consolidated Financial Results for the Six Months Ended February 28, 2025 [Japanese GAAP] pdf (442KB)
  • Apr 01, 2025 Presentation of data from our pipeline at the American Association for Cancer Research Annual Meeting 2025 pdf (233KB)
  • Jan 14, 2025 Non-consolidated Financial Results for the Three Months Ended November 30, 2024 [Japanese GAAP] pdf (432KB)
  • Jan 10, 2025 Rogocekib for the treatment of Refractory or Relapsed Acute Myologic Lymphoma(AML) has been granted Orphan Drug Designation (ODD) in the US by the FDA pdf (272KB)
  • Dec 12, 2024 By FISCO Corporation Notice of Distribution of Our Corporate Research Report pdf (267KB)
  • Nov 29, 2024 Corporate Governance Report pdf (659KB)
  • Nov 20, 2024 Announcement of International Nonproprietary Name (INN) for CTX-712 pdf (277KB)
  • Oct 28, 2024 Chordia announces the Release of a Transcript of the Earnings Briefing for the Fiscal Year Ended August 2024 pdf (281KB)
  • Oct 15, 2024 Fiscal year ended August 2024 Financial Results Presentation pdf (1,465KB)
  • Oct 11, 2024 Non-consolidated Financial Results for the Fiscal Year Ended August 31, 2024 [Japanese GAAP] pdf (538KB)
  • Oct 11, 2024 Chordia to Present Results of Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2024 The 86th Annual Meeting of the Japanese Society of Hematolog pdf (283KB)
  • Oct 01, 2024 Announcement of Presentation on Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 86th Annual Meeting of the Japanese Society of Hematology pdf (281KB)
  • Jul 23, 2024 Chordia wins the Minister of Education, Culture, Sports, Science and Technology Award at the Japan Startup Awards 2024. pdf (610KB)
  • Jul 16, 2024 Non-consolidated Financial Results for the Nine Months Ended May 31, 2024 [Japanese GAAP] pdf (348KB)

VIEW IR NEWS

ページの先頭へ
ページの先頭へ
  • footer-content
  • menu
  • gnavi-box